This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. The Food and Drug Administration updated the recall notice ...

FILE PHOTO: FILE PHOTO: Signage is seen outside of FDA headquarters in White Oak, Maryland (Reuters) -The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific's ...

Boston Scientific (NYSE:BSX) has issued a corrective recall for its embolization agent Obsidio, warning that the product should not be administered using the aliquot technique. The FDA has classified ...

Boston Scientific’s Obsidio Conformable Embolic recall was recently hit with FDA’s Class I classification. The recall is categorized as a correction, not a product removal and comes after the company ...

The Obsidio Conformable Embolic recall related to an increased risk for bowel ischemia is the most serious kind, the FDA said on Wednesday, citing two deaths associated with the issue. An ...

The FDA recently announced critical recalls on several widely used medical devices, including Life2000 ventilators, Medtronic’s MiniMed insulin pumps and Boston Scientific’s Obsidio conformable ...

Medical technology manufacturing company Boston Scientific has acquired Obsidio, a company that makes technology used in the embolization of blood vessels in the peripheral vasculature. Embolization ...

Boston Scientific's latest tuck-in acquisition could prove to be quite a "gem." The Marlborough, MA-based company announced the acquisition of Obsidio, a privately-held startup that has developed the ...

COLUMBIA, S.C., Aug. 6, 2020 /PRNewswire/ -- Obsidio, Inc., a pre-clinical stage medical materials developer, today announced the closing of a $3 million round led by IAG Capital Partners. Returning ...

On Wednesday, Boston Scientific Corporation (NYSE:BSX) said it recalled Obsidio Embolic by issuing a correction. The FDA has identified this as a Class I recall, the most severe type of recall. An ...